scholarly article | Q13442814 |
P50 | author | Stavros Garantziotis | Q42388074 |
Maria Shatz | Q53337141 | ||
Michael A Resnick | Q62124589 | ||
Michael B Fessler | Q63363549 | ||
P2093 | author name string | Daniel Menendez | |
Kathleen Azzam | |||
P2860 | cites work | In vivo activation of the p53 pathway by small-molecule antagonists of MDM2 | Q27642888 |
p53, the cellular gatekeeper for growth and division | Q27860990 | ||
Definition of a consensus binding site for p53 | Q28207794 | ||
A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response | Q28592069 | ||
p53 Functions through Stress- and Promoter-Specific Recruitment of Transcription Initiation Components before and after DNA Damage | Q28609701 | ||
Circulating mitochondrial DAMPs cause inflammatory responses to injury | Q29614470 | ||
Transcriptional control of human p53-regulated genes | Q29617650 | ||
Estrogen receptor acting in cis enhances WT and mutant p53 transactivation at canonical and noncanonical p53 target sequences | Q30493233 | ||
microRNAs join the p53 network--another piece in the tumour-suppression puzzle | Q33344707 | ||
Noncanonical DNA motifs as transactivation targets by wild type and mutant p53 | Q33361623 | ||
Triggering of TLR7 and TLR8 expressed by human lung cancer cells induces cell survival and chemoresistance | Q33755300 | ||
Functionally distinct polymorphic sequences in the human genome that are targets for p53 transactivation. | Q33772124 | ||
Genetic variation in radiation-induced expression phenotypes | Q33910447 | ||
A SNP in the flt-1 promoter integrates the VEGF system into the p53 transcriptional network | Q34334913 | ||
Regulation of lung injury and repair by Toll-like receptors and hyaluronan | Q34462186 | ||
The biological impact of the human master regulator p53 can be altered by mutations that change the spectrum and expression of its target genes | Q34519833 | ||
Regulation of adaptive immunity by the innate immune system | Q34659642 | ||
An agonist of toll-like receptor 5 has radioprotective activity in mouse and primate models | Q34769152 | ||
Functional evolution of the p53 regulatory network through its target response elements | Q36458961 | ||
Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists | Q36811131 | ||
TLR2 is expressed on activated T cells as a costimulatory receptor | Q36853515 | ||
The effect of toll-like receptors and toll-like receptor genetics in human disease | Q36936332 | ||
ROS and p53: a versatile partnership | Q37085000 | ||
Probing the functional impact of sequence variation on p53-DNA interactions using a novel microsphere assay for protein-DNA binding with human cell extracts | Q37154221 | ||
Intestinal mucosal inflammation leads to systemic genotoxicity in mice | Q37259554 | ||
Deficiency of the DNA repair enzyme ATM in rheumatoid arthritis | Q37273198 | ||
A regulatory loop composed of RAP80-HDM2-p53 provides RAP80-enhanced p53 degradation by HDM2 in response to DNA damage. | Q37339272 | ||
Pattern recognition receptors and control of adaptive immunity | Q37361471 | ||
Oxidative damage to nucleic acids in severe emphysema | Q37395759 | ||
The expanding universe of p53 targets | Q37602507 | ||
Pattern recognition by Toll-like receptors | Q37607209 | ||
Targeting Toll-like receptors: emerging therapeutics? | Q37727910 | ||
p53 regulates Toll-like receptor 3 expression and function in human epithelial cell lines | Q39941925 | ||
p53-induced up-regulation of MnSOD and GPx but not catalase increases oxidative stress and apoptosis. | Q40571016 | ||
A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy | Q40929887 | ||
Differential regulation of p53 target genes: it's (core promoter) elementary. | Q42044986 | ||
Role of toll-like receptor 2 (TLR2) in neutrophil activation: GM-CSF enhances TLR2 expression and TLR2-mediated interleukin 8 responses in neutrophils. | Q44102020 | ||
Toll-like receptors stimulate human neutrophil function | Q44493366 | ||
Differential expression and regulation of toll-like receptors (TLR) in human leukocytes: selective expression of TLR3 in dendritic cells | Q45345615 | ||
Differential expression of Toll-like receptor (TLR)-2 and TLR-4 on monocytes in human sepsis | Q47759466 | ||
Damage effects of dust storm PM2.5 on DNA in alveolar macrophages and lung cells of rats. | Q51055950 | ||
Control of B-cell responses by Toll-like receptors | Q59066168 | ||
Toll-like receptors control activation of adaptive immune responses | Q74486847 | ||
Increased expression of toll-like receptor-2 and -4 on leukocytes from patients with sepsis | Q80873411 | ||
Inhibition of immunological function mediated DNA damage of alveolar macrophages caused by cigarette smoke in mice | Q84922234 | ||
P275 | copyright license | Creative Commons CC0 License | Q6938433 |
P6216 | copyright status | copyrighted, dedicated to the public domain by copyright holder | Q88088423 |
P433 | issue | 3 | |
P921 | main subject | toll-like receptor | Q408004 |
DNA damage | Q5205747 | ||
P304 | page(s) | e1001360 | |
P577 | publication date | 2011-03-31 | |
P1433 | published in | PLOS Genetics | Q1893441 |
P1476 | title | The Toll-like receptor gene family is integrated into human DNA damage and p53 networks | |
P478 | volume | 7 |
Q36016499 | A p53 axis regulates B cell receptor-triggered, innate immune system-driven B cell clonal expansion |
Q54858643 | Antigenotoxic Effect of Trametes spp. Extracts against DNA Damage on Human Peripheral White Blood Cells. |
Q35077769 | Association of TLR2 and TLR4 polymorphisms with risk of cancer: a meta-analysis |
Q41432461 | CHK1 and RAD51 activation after DNA damage is regulated via urokinase receptor/TLR4 signaling |
Q40858725 | CRN13 candidate effectors from plant and animal eukaryotic pathogens are DNA-binding proteins which trigger host DNA damage response. |
Q27692076 | Caught in the cross fire: p53 in inflammation. |
Q27692108 | Cellular stress response and innate immune signaling: integrating pathways in host defense and inflammation. |
Q38911126 | Census and evaluation of p53 target genes. |
Q38940069 | Cooperative interactions between p53 and NFκB enhance cell plasticity. |
Q36254960 | Cytokine response in mouse bone marrow derived macrophages after infection with pathogenic and non-pathogenic Rift Valley fever virus |
Q28078628 | DNA Damage: From Chronic Inflammation to Age-Related Deterioration |
Q36068346 | DNA repair is indispensable for survival after acute inflammation |
Q35737507 | Distinct p53 genomic binding patterns in normal and cancer-derived human cells |
Q37122075 | Diverse stresses dramatically alter genome-wide p53 binding and transactivation landscape in human cancer cells |
Q38838059 | Downregulation of Toll-Like Receptor 9 Expression by Beta Human Papillomavirus 38 and Implications for Cell Cycle Control. |
Q33890980 | Dynamic expression patterns of ATF3 and p53 in the hippocampus of a pentylenetetrazole-induced kindling model |
Q58416369 | ETV7-Mediated DNAJC15 Repression Leads to Doxorubicin Resistance in Breast Cancer Cells |
Q36127825 | Effects of P-MAPA Immunomodulator on Toll-Like Receptors and p53: Potential Therapeutic Strategies for Infectious Diseases and Cancer |
Q93378245 | Encephalitozoon cuniculi and Vittaforma corneae (Phylum Microsporidia) inhibit staurosporine-induced apoptosis in human THP-1 macrophages in vitro |
Q34325529 | Fuzzy tandem repeats containing p53 response elements may define species-specific p53 target genes |
Q45089227 | Gene set enrichment analysis highlights different gene expression profiles in whole blood samples X-irradiated with low and high doses |
Q38726846 | Genetic Variability as a Regulator of TLR4 and NOD Signaling in Response to Bacterial Driven DNA Damage Response (DDR) and Inflammation: Focus on the Gastrointestinal (GI) Tract |
Q35668596 | Genomic regulation of senescence and innate immunity signaling in the retinal pigment epithelium |
Q36070462 | Increased toll-like receptors and p53 levels regulate apoptosis and angiogenesis in non-muscle invasive bladder cancer: mechanism of action of P-MAPA biological response modifier |
Q90062620 | Inflammaging and Oxidative Stress in Human Diseases: From Molecular Mechanisms to Novel Treatments |
Q51731314 | Innate immune system activation in zebrafish and cellular models of Diamond Blackfan Anemia. |
Q36906240 | Interaction between p53 and estradiol pathways in transcriptional responses to chemotherapeutics |
Q64943265 | Key mechanisms involved in ionizing radiation-induced systemic effects. A current review. |
Q37641651 | Ligand dependent restoration of human TLR3 signaling and death in p53 mutant cells. |
Q31156407 | Microbial pathogens trigger host DNA double-strand breaks whose abundance is reduced by plant defense responses |
Q37584840 | Mouse embryonic stem cells undergo charontosis, a novel programmed cell death pathway dependent upon cathepsins, p53, and EndoG, in response to etoposide treatment |
Q37110140 | Network analysis reveals centrally connected genes and pathways involved in CD8+ T cell exhaustion versus memory. |
Q93105342 | Overcoming adaptive therapy resistance in AML by targeting immune response pathways |
Q36887608 | PDL1 Regulation by p53 via miR-34 |
Q37018148 | Pathways analysis of differential gene expression induced by engrafting doses of total body irradiation for allogeneic bone marrow transplantation in mice |
Q38690773 | Pattern recognition receptors: immune targets to enhance cancer immunotherapy |
Q38739590 | Predicting RTS,S Vaccine-Mediated Protection from Transcriptomes in a Malaria-Challenge Clinical Trial |
Q35717532 | Primed for cancer: Li Fraumeni Syndrome and the pre-cancerous niche |
Q59136284 | RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation |
Q38284081 | Radiation and inflammation |
Q36083353 | Radiation takes its Toll |
Q50221002 | Relationship between radioadaptive response and individual radiosensitivity to low doses of gamma radiation: an extended study of chromosome damage in blood lymphocytes of three donors |
Q58788860 | Revealing a human p53 universe |
Q30009394 | STAT1-induced ASPP2 transcription identifies a link between neuroinflammation, cell polarity, and tumor suppression |
Q42043686 | Salicylic acid activates DNA damage responses to potentiate plant immunity |
Q38038940 | TLR signaling and DNA repair: are they associated? |
Q40131966 | TLR1-10, NF-κB and p53 expression is increased in oral lichenoid disease |
Q40721174 | TLR2∆22 (-196-174) significantly increases the risk of breast cancer in females carrying proline allele at codon 72 of TP53 gene: a case-control study from four ethnic groups of North Eastern region of India. |
Q92989385 | TLR5 participates in the TLR4 receptor complex and promotes MyD88-dependent signaling in environmental lung injury |
Q37991536 | Targeting pattern recognition receptors in cancer immunotherapy. |
Q40319984 | The Cytidine Deaminase APOBEC3 Family Is Subject to Transcriptional Regulation by p53. |
Q90598608 | The Inhibitory Mechanisms of Tumor PD-L1 Expression by Natural Bioactive Gallic Acid in Non-Small-Cell Lung Cancer (NSCLC) Cells |
Q35958116 | The effects of storage temperature on PBMC gene expression |
Q36237533 | The human TLR innate immune gene family is differentially influenced by DNA stress and p53 status in cancer cells |
Q50356776 | The novel p53 target TNFAIP8 variant 2 is increased in cancer and offsets p53-dependent tumor suppression. |
Q24273295 | The transcription factor p53: not a repressor, solely an activator |
Q27026790 | Transcriptional Activation of Inflammatory Genes: Mechanistic Insight into Selectivity and Diversity |
Q36231932 | p53 amplifies Toll-like receptor 5 response in human primary and cancer cells through interaction with multiple signal transduction pathways |
Q37714779 | p53 and NF-κB coregulate proinflammatory gene responses in human macrophages |
Q92726625 | p53-responsive TLR8 SNP enhances human innate immune response to respiratory syncytial virus |
Search more.